AKERO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Mar 2026)
What this means for you
Registered since 22 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88979629
- Registration number
- 6228033
- Mark type
- Stylized text
- Filed
- 22 Aug 2018
- Published for opposition
- 06 Aug 2019
- Registered
- 22 Dec 2020
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals; clinical research in the field of pharmaceuticals
Owner
- Akero Therapeutics, Inc., South San Francisco, CA, US
- Akero Therapeutics, Inc., South San Francisco, CA, US
- Akero Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 30 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Mar 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jan 2026 — TEAS SECTION 8 & 15 RECEIVED
- 22 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Jun 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Jun 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 19 Nov 2020 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 28 Sept 2020 — NOTICE OF ALLOWANCE CANCELLED
- 19 Nov 2020 — DIVISIONAL PROCESSING COMPLETE